ScoreWhy is Beijing Winsunny Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 3.36% and Operating profit at 11.86% over the last 5 years
2
Negative results in Sep 25
- OPERATING CASH FLOW(Y) Lowest at CNY 538.37 MM
- ROCE(HY) Lowest at 12.97%
- DEBT-EQUITY RATIO (HY) Highest at -55.34 %
3
With ROE of 13.08%, it has a attractive valuation with a 2.94 Price to Book Value
- Over the past year, while the stock has generated a return of 55.26%, its profits have fallen by -12.1%
4
Market Beating Performance
- The stock has generated a return of 55.26% in the last 1 year, much higher than market (China Shanghai Composite) returns of 22.49%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Beijing Winsunny Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Beijing Winsunny Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Beijing Winsunny Pharmaceutical Co., Ltd.
46.45%
1.19
51.74%
China Shanghai Composite
16.01%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.36%
EBIT Growth (5y)
11.86%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.60
Sales to Capital Employed (avg)
0.96
Tax Ratio
8.77%
Dividend Payout Ratio
48.23%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
36.39%
ROE (avg)
17.86%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
22
Industry P/E
Price to Book Value
2.94
EV to EBIT
18.10
EV to EBITDA
14.52
EV to Capital Employed
5.42
EV to Sales
2.52
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
29.94%
ROE (Latest)
13.08%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-10What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CNY 538.37 MM
ROCE(HY)
Lowest at 12.97%
DEBT-EQUITY RATIO
(HY)
Highest at -55.34 %
INVENTORY TURNOVER RATIO(HY)
Lowest at 3.25 times
OPERATING PROFIT(Q)
Lowest at CNY 109.64 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 12.37 %
Here's what is not working for Beijing Winsunny Pharmaceutical Co., Ltd.
Operating Cash Flow
Lowest at CNY 538.37 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Debt-Equity Ratio
Highest at -55.34 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Operating Profit
Lowest at CNY 109.64 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 12.37 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Inventory Turnover Ratio
Lowest at 3.25 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
